The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The combination will support clients in getting their end-to-end discovery and development programs delivered.
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
Subscribe To Our Newsletter & Stay Updated
